Screener
Corvus Pharmaceuticals CRVS Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProfitLoss.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's net income?
- Corvus Pharmaceuticals (CRVS) reported net income of -$13.69M in Q1 2026.
- How has Corvus Pharmaceuticals's net income changed year-over-year?
- Corvus Pharmaceuticals's net income decreased by 190.1% year-over-year, from $15.19M to -$13.69M.
- What is the long-term trend for Corvus Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's net income has grown at a -22.9% compound annual growth rate (CAGR), from -$43.24M to -$15.28M.
- What does net income mean?
- Net income as the starting point for the indirect method operating cash flow reconciliation.
Ask your AI about Corvus Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude